Sort   by:  
 Page size 
UnknownWork ability and quality of working life in atopic dermatitis patients treated with dupilumab.
Not available
S-EPMC8453967 | biostudies-literature
UnknownComparison of real-world treatment outcomes of systemic immunomodulating therapy in atopic dermatitis patients with dark and light skin types.
Not available
S-EPMC9661502 | biostudies-literature
UnknownDevelopment and initial testing of a new instrument to measure the experience of eczema control in adults and children: Recap of atopic eczema (RECAP).
Not available
S-EPMC7496132 | biostudies-literature
UnknownImmunogenicity and 1-year boostability of a three-dose intramuscular rabies pre-exposure prophylaxis schedule in adults receiving immunosuppressive monotherapy: a prospective single-centre clinical trial.
Not available
S-EPMC10075057 | biostudies-literature
UnknownThe UPDATE trial (UVB Phototherapy in Dermatology for ATopic Eczema): study protocol for a randomized controlled trial of narrowband UVB with optimal topical therapy versus optimal topical therapy in patients with atopic eczema.
Not available
S-EPMC11253338 | biostudies-literature
UnknownA core outcome domain set for clinical research on capillary malformations (the COSCAM project): an e-Delphi process and consensus meeting.
Not available
S-EPMC9796083 | biostudies-literature
UnknownPrimary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity.
Not available
S-EPMC10189216 | biostudies-literature
UnknownImpact of COVID-19 disease and vaccination on dermatological immune-mediated inflammatory diseases atopic dermatitis, psoriasis, and vitiligo: a Target2B! substudy.
Not available
S-EPMC11975183 | biostudies-literature
UnknownGlobal reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic.
Not available
S-EPMC7267275 | biostudies-literature
UnknownAssociation Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19.
Not available
S-EPMC8524310 | biostudies-literature
Sort   by:  
 Page size